This is an important finding, since the mammalian homolog of ZYG-8 (DCLK1/doublecortin-like kinase 1) is upregulated in a wide range of cancers, and knockdown studies have suggested that it is required for tumor progression. This evidence concerns the gene DCLK1 and neoplasm.